Detection of miRNA as non-invasive biomarkers of colorectal cancer

International Journal of Molecular Sciences

Volumn 16, Issue 2, 2015, Pages 2810-2823

  Ren, Albert ^a,b   Dong, Yujuan ^a,c   Tsoi, Ho ^a   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biomarker; Circulatory; Colorectal cancer; Diagnostic; Fecal; miRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 134; MICRORNA 135; MICRORNA 135B; MICRORNA 15B; MICRORNA 17; MICRORNA 181B; MICRORNA 183; MICRORNA 18A; MICRORNA 195; MICRORNA 19A; MICRORNA 19B; MICRORNA 203; MICRORNA 20A; MICRORNA 21; MICRORNA 214; MICRORNA 221; MICRORNA 29A; MICRORNA 31; MICRORNA 331; MICRORNA 335; MICRORNA 532; MICRORNA 652; MICRORNA 7; MICRORNA 92A; MICRORNA 96; UNCLASSIFIED DRUG; UNINDEXED DRUG; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

APOPTOSIS; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL CANCER; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FECES ANALYSIS; HUMAN; NON INVASIVE MEASUREMENT; REVIEW; SENSITIVITY AND SPECIFICITY; BLOOD; CHEMISTRY; COLORECTAL NEOPLASMS; FECES; GENETICS; METABOLISM;

BIOMARKERS, TUMOR; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FECES; HUMANS; MICRORNAS;

EID: 84921898902     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16022810     Document Type: Review

References (59)

1. Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 2014, 136, E359-E386.
2. Sung, J.J.; Lau, J.Y.; Young, G.P.; Sano, Y.; Chiu, H.M.; Byeon, J.S.; Yeoh, K.G.; Goh, K.L.; Sollano, J.; Rerknimitr, R.; et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer. Gut 2014, 64, 1-12.
3. American Cancer Society. Available Online: http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-risk-factors (accessed on 2 November 2014).
4. Kawamura, M.; Toiyama, Y.; Tanaka, K.; Inoue, Y.; Mohri, Y.; Kusunoki, M. Can circulating microRNAs become the test of choice for colorectal cancer? Curr. Colorectal Cancer Rep. 2014, 10, 403-410.
5. Sung, J.J.; Lau, J.Y.; Young, G.P.; Sano, Y.; Chiu, H.M.; Byeon, J.S.; Yeoh, K.G.; Goh, K.L.; Sollano, J.; Rerknimitr, R.; et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 2008, 57, 1166-1176.
6. Ng, S.C.; Wong, S.H. Colorectal cancer screening in Asia. Br. Med. Bull. 2013, 105, 29-42.
7. Ahmed, F.E.; Amed, N.C.; Vos, P.W.; Bonnerup, C.; Atkins, J.N.; Casey, M.; Nuovo, G.J.; Naziri, W.; Wiley, J.E.; Allison, R.R. Diagnostic microRNA markers to screen for sporadic human colon cancer in blood. Cancer Genomics Proteomics 2012, 9, 179-192.
8. Dong, Y.; Wu, W.K.K.; Wu, C.W.; Sung, J.J.Y.; Yu, J.; Ng, S.S.M. MicroRNA dysregulation in colorectal cancer: A clinical perspective. Br. J. Cancer 2011, 104, 893-898.
9. Kumaravel, V.; Hayden, S.P.; Hall, G.S.; Burke, C. New fecal occult blood tests may improve adherence and mortality rates. Clevel. Clin. J. Med. 2011, 78, 515-520.
10. Bartel, D.P.; Lee, R.; Feinbaum, R. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297.
11. Hrašovec, S.; Glava, D. MicroRNAs as novel biomarkers in colorectal cancer. Front. Genet. 2012, 3, 1-9.
12. Wang, K.; Yuan, Y.; Cho, J.; McClarty, S.; Baxter, D.; Galas, D.J. Comparing the MicroRNA spectrum between serum and plasma. PLoS One 2012, 7, e41561.
13. Cheng, H.H.; Yi, H.S.; Kim, Y.; Kroh, E.M.; Chien, J.W.; Eaton, K.D.; Goodman, M.T.; Tait, J.F.; Tewari, M.; Pritchard, C.C. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One 2013, 8, e64795.
14. Kroh, E.M.; Parkin, R.K.; Mitchell, P.S.; Tewari, M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50, 298-301.
15. Monleau, M.; Bonnel, S.; Gostan, T.; Blanchard, D.; Courgnaud, V. Comparison of differentextraction techniques to profile microRNAs from human sera and peripheral blood mononuclearcells. BMC Genomics 2014, 15, doi:10.1186/1471-2164-15-395.
16. Li, Y.; Kowdley, K.V. Method for microRNA isolation from clinical serum samples.Anal. Biochem. 2012, 431, 69-75.
17. Baker, M. MicroRNA profiling: Separating signal from noise. Nat. Publ. Group 2010, 7, 687-692.
18. Benes, V.; Castoldi, M. Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Methods 2010, 50, 244-249.
19. Stahlberg, A.; Kubista, M.; Pfaffl, M. Comparison of reverse transcriptases in gene expression analysis. Clin. Chem. 2004, 50, 1678-1680.
20. Vandesompele, J.; de Preter, K.; Pattyn, F.; Poppe, B.; van Roy, N.; de Paepe, A.; Speleman, F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3, doi:10.1186/gb-2002-3-7-research0034.
21. Chugh, P.; Dittmer, D.P. Potential pitfalls in microRNA profiling. Wiley Interdiscip. Rev. RNA 2012, 3, 601-616.
22. Pritchard, C.C.; Kroh, E.; Wood, B.; Arroyo, J.D.; Dougherty, K.J.; Miyaji, M.M.; Tait, J.F.; Tewari, M. Blood cell origin of circulating microRNAs: A cautionary note for cancer biomarker studies. Cancer Prev. Res. 2012, 5, 492-497.
23. McDonald, J.S.; Milosevic, D.; Reddi, H.V.; Grebe, S.K.; Algeciras-Schimnich, A. Analysis of circulating microRNA: Preanalytical and Analytical Challenges. Clin. Chem. 2011, 57, 833-840.
24. Song, J.; Bai, Z.; Han, W.; Zhang, J.; Meng, H.; Bi, J.; Ma, X.; Han, S.; Zhang, Z. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig. Dis. Sci. 2012, 57, 897-904.
25. Day, E.; Dear, P.H.; McCaughan, F. Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine. Methods 2013, 59, 101-107.
26. Hindson, C.M.; Chevillet, J.R.; Briggs, H.A.; Gallichotte, E.N.; Ruf, I.K.; Hindson, B.J.; Vessella, R.L.; Tewari, M. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat. Methods 2013, 10, 1003-1005.
27. Locker, G.Y.; Hamilton, S.; Harris, J.; Jessup, J.M.; Kemeny, N.; Macdonald, J.S.; Somerfield, M.R.; Hayes, D.F.; Bast, R.C. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol. 2006, 24, 5313-5327.
28. Lawrie, C.H.; Gal, S.; Dunlop, H.M.; Pushkaran, B.; Liggins, A.P.; Pulford, K.; Banham, A.H.; Pezzella, F.; Boultwood, J.; Wainscoat, J.S.; et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large b-cell lymphoma. Br. J. Haematol. 2008, 141, 672-675.
29. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O’Briant, K.C.; Allen, A.; et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518.
30. Arroyo, J.D.; Chevillet, J.R.; Kroh, E.M.; Ruf, I.K.; Pritchard, C.C.; Gibson, D.F.; Mitchell, P.S.; Bennett, C.F.; Pogosova-Agadjanyan, E.L.; Stirewalt, D.L.; et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. USA 2011, 108, 5003-5008.
31. Turchinovich, A.; Weiz, L.; Langheinz, A.; Burwinkel, B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011, 39, 7223-7233.
32. Vickers, K.C.; Remaley, A.T. Lipid-based carriers of microRNAs and intercellular communication. Curr. Opin. Lipidol. 2012, 23, 91-97.
33. Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature 2007, 9, 654-659.
34. Tsuchida, A.; Ohno, S.; Wu, W.; Borjigin, N.; Fujita, K.; Aoki, T.; Ueda, S.; Takanashi, M.; Kuroda, M. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci. 2011, 102, 2264-2271.
35. Diosdado, B.; van de Wiel, M.A.; Terhaar Sive Droste, J.S.; Mongera, S.; Postma, C.; Meijerink, W.J.H.J.; Carvalho, B.; Meijer, G.A. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br. J. Cancer 2009, 101, 707-714.
36. Ng, E.K.O.; Chong, W.W.S.; Jin, H.; Lam, E.K.Y.; Shin, V.Y.; Yu, J.; Poon, T.C.W.; Ng, S.S.M.; Sung, J.J.Y. Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut 2009, 58, 1375-1381.
37. Huang, Z.; Huang, D.; Ni, S.; Peng, Z.; Sheng, W.; Du, X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 2010, 126, 118-126.
38. Schee, K.; Boye, K.; Abrahamsen, T.W.; Fodstad, Ø.; Flatmark, K. Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC Cancer 2012, 12, doi:10.1186/1471-2407-12-505.
39. Shigoka, M.; Tsuchida, A.; Matsudo, T.; Nagakawa, Y.; Saito, H.; Suzuki, Y.; Aoki, T.; Murakami, Y.; Toyoda, H.; Kumada, T.; et al. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol. Int. 2010, 60, 351-357.
40. Si, H.; Sun, X.; Chen, Y.; Cao, Y.; Chen, S.; Wang, H.; Hu, C. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J. Cancer Res. Clin. Oncol. 2013, 139, 223-229.
41. Jiang, Y.; Wang, H.; Cao, H.; Wang, C.; Zhang, L.; Wang, H.; Liu, L.; Li, Y.; Cai, J. Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci. Rep. 2014, 4, doi:10.1038/srep05026.
42. Asangani, I.A.; Rasheed, S.A.; Nikolova, D.A.; Leupold, J.H.; Colburn, N.H.; Post, S.; Allgayer, H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27, 2128-2136.
43. Kanaan, Z.; Rai, S.N.; Eichenberger, M.R.; Roberts, H.; Keskey, B.; Pan, J.; Galandiuk, S. Plasma miR-21: A potential diagnostic marker of colorectal cancer. Ann. Surg. 2012, 256, 544-551.
44. Luo, X.; Stock, C.; Burwinkel, B.; Brenner, H. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PLoS One 2013, 8, e62880.
45. Köberle, V.; Pleli, T.; Schmithals, C.; Augusto Alonso, E.; Haupenthal, J.; Bönig, H.; Peveling-Oberhag, J.; Biondi, R.M.; Zeuzem, S.; Kronenberger, B.; et al. Differential stability of cell-free circulating microRNAs: Implications for their utilization as biomarkers. PLoS One 2013, 8, e75184.
46. Kanaan, Z.; Roberts, H.; Eichenberger, M.R.; Billeter, A.; Ocheretner, G.; Pan, J.; Rai, S.N.; Jorden, J.; Williford, A.; Galandiuk, S. A plasma microRNA panel for detection of colorectal adenomas: A step toward more precise screening for colorectal cancer. Ann. Surgery 2013, 258, 400-408.
47. Giráldez, M.D.; Lozano, J.J.; Ramírez, G.; Hijona, E.; Bujanda, L.; Castells, A.; Gironella, M. Circulating microRNAs as biomarkers of colorectal cancer: Results from a genome-wide profiling and validation study. Clin. Gastroenterol. Hepatol. 2013, 11, 681-688.
48. Wang, J.; Huang, S.; Zhao, M.; Yang, M.; Zhong, J.; Gu, Y.; Peng, H.; Che, Y.; Huang, C. Identification of a circulating microRNA signature for colorectal cancer detection. PLoS One 2014, 9, e87451.
49. Morikawa, T.; Kato, J.; Yamaji, Y.; Wada, R.; Mitsushima, T.; Shiratori, Y. A Comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005, 129, 422-428.
50. Ahmed, F.E.; Jeffries, C.D.; Vos, P.W.; Flake, G.; Nuovo, G.J.; Sinar, D.R.; Naziri, W.; Marcuard, S.P. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics 2009, 6, 281-295.
51. Ahlquist, D.A. Molecular detection of colorectal neoplasia. Gastroenterology 2010, 138, 2127-2139.
52. Fearon, E.R.; Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 1990, 61, 759-767.
53. Slaby, O.; Svoboda, M.; Michalek, J.; Vyzula, R. MicroRNAs in colorectal cancer: Translation ofmolecular biology into clinical application. Mol. Cancer 2009, 8, doi:10.1186/1476-4598-8-102.
54. Kuo, Y.B.; Chan, E.C.; Chen, J.S.; Shieh, F.K. Fecal miRNAS as biomarkers for the detection of colorectal cancer. J. Gastrointest. Dig. Syst. 2013, doi:10.4172/2161-069X.S12-016.
55. Wu, C.W.; Ng, S.C.; Dong, Y.; Tian, L.; Ng, S.S.M.; Leung, W.W.; Law, W.T.; Yau, T.O.; Chan, F.K.L.; Sung, J.J.Y.; et al. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma. Clin. Cancer Res. 2014, 20, 2994-3002.
56. Yau, T.O.; Wu, C.W.; Dong, Y.; Tang, C.-M.; Ng, S.S.M.; Chan, F.K.L.; Sung, J.J.Y.; Yu, J. microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma. Br. J. Cancer 2014, 111, 1765-1771.
57. Wu, C.W.; Ng, S.S.M.; Dong, Y.J.; Ng, S.C.; Leung, W.W.; Lee, C.W.; Wong, Y.N.; Chan, F.K.L.; Yu, J.; Sung, J.J.Y. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012, 61, 739-745.
58. Koga, Y.; Yasunaga, M.; Takahashi, A.; Kuroda, J.; Moriya, Y.; Akasu, T.; Fujita, S.; Yamamoto, S.; Baba, H.; Matsumura, Y. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev. Res. 2010, 3, 1435-1442.
59. Ahmed, F.E.; Ahmed, N.C.; Vos, P.W.; Bonnerup, C.; Atkins, J.N.; Casey, M.; Nuovo, G.J.; Naziri, W.; Wiley, J.E.; Mota, H.; et al. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of Principle. Cancer Genomics Proteomics 2013, 10, 93-113.